Impact of human genome sequencing for in silico target discovery

Drug Discovery Today

Volumn 6, Issue 6, 2001, Pages 316-323

  Sanseau, Philippe ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME;

DATA BASE; DRUG TARGETING; GENE SEQUENCE; GENOME; HUMAN; INFORMATION SCIENCE; PREDICTION; REVIEW;

EID: 0035282786     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)01724-X     Document Type: Review

References (80)

1. The DNA sequence of human chromosome 22
2. The DNA sequence of human chromosome 21
3. Human whole-genome shotgun sequencing
4. Shotgun sequencing of the human genome
5. Whole-genome random sequencing and assembly of Haemophilus influenzae
6. A whole-genome assembly of Drosophila
7. Rapid cDNA sequencing (expressed sequence tags) from a directionally cloned human infant brain cDNA library
8. The Merck Gene Index project
9. Cathepsin K, but not cathepsins B, L or S, is abundantly expressed in human osteoclasts
10. How many genes in the human genome?
11. Analysis of expressed sequence tags indicates 35 000 human genes
12. Gene index analysis of the human genome estimates approximately 120 000 genes
13. Estimate of human gene number provided by genome-wide analysis using Tetraodon nigroviridis DNA sequence
14. The genome sequence of Drosophila melanogaster
15. Basic alignment search tool
16. Gene recognition via spliced alignment
17. Dynamite: a flexible code generating language for dynamic programming methods used in sequence comparison
18. Prediction of complete gene structures in human genomic DNA
19. Locating protein-coding regions in DNA sequences by a multiple sensor-neural approach
20. An assessment of gene prediction accuracy in large DNA sequences
21. From bioinformatics to computational biology
22. Computational methods for exon detection
23. Eukaryotic promoter recognition
24. Gene finding approaches for eukaryotes
25. Comparing the success of different prediction software in sequence analysis: a review
26. Genomic sciences and the medicine of tomorrow
27. The role of innovation in drug development
28. Drug discovery: a historical perspective
29. Pharmacogenetics and the practice of medicine
30. A novel family of mammalian taste receptors
31. The impact of genomics on drug discovery
32. Identification and characterization of a novel human cortistatin-like peptide
33. Ligand-receptor pairing via tree comparison
34. Assessing the protease and protease inhibitor content of the human genome
35. A new dynamic tool to perform assembly of expressed sequence tags, ESTs
36. In silico cloning of a new protein kinase, Aik2, related to Drosophila aurora using the new tool: EST Blast
37. Cloning and functional expression of a human orthologue of rat vanilloid receptor-1
38. A combined algorithm for genome-wide prediction of protein function
39. Apolipoprotein E affects the rate of Alzheimer's disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of the disease
40. A 4-Mb high-density single nucleotide polymorphism-based map around human ApoE
41. Complex promoter and coding region of β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness
42. Real time quantitative PCR
43. A novel method for real time quantitative RT-PCR
44. Expression monitoring by hybridization to high-density oligonucleotide arrays
45. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
46. DNA microarrays in drug discovery and development
47. Genomics, gene expression and DNA arrays
48. Microarrays and toxicology: the advent of toxicogenomics
49. Mutational analysis using oligonucleotide arrays
50. Resequencing and mutational analysis using oligonucleotide microarrays
51. Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays
52. Data management and analysis for gene expression arrays
53. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring
54. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
55. Molecular portraits of human breast tumours
56. Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks
57. The transcriptional program in the response of human fibroblasts to serum
58. Cluster analysis and display of genome-wide expression patterns
59. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation
60. Functional discovery via a compendium of expression profiles
61. Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization
62. Promoter analysis of co-regulated genes in the yeast genome
63. From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis
64. Proteomics to study genes and genomes
65. Automation of matrix assisted laser desorption/ionization mass spectrometry using fuzzy logic feedback control
66. Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints
67. A novel genetic system to detect protein-protein interactions
68. Printing proteins as microarrays for high-throughput function determination
69. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae
70. Detecting protein function and protein-protein interactions from genome sequences
71. Wiggling and undulating out of an X-ray shortage
72. Crystal structure of Rhodopsin: a G protein-coupled receptor
73. + conduction and selectivity
74. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor
75. Implication of tubby proteins as transcription factors by structure-based functional analysis
76. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations
77. Creating a structural genomics consortium